newsroom.

Cosette’s Clomid® 50mg Tablets are now available to patients and pharmacies from the major US wholesalers and distributors.  Clomid® is packaged in a 10 count carton (NDC #00713-0885-09) and a 30 count carton (NDC #00713-0885-30). Also now available from Cosette are Azor, Benicar, Benicar HCT, Effient, Evoxac, Tribenzor and Welchol.  Product is available from the major US wholesalers and distributors using the following NDC numbers.

Ganesh Pillarisetti has joined the executive team as Vice President, IT at Cosette Pharmaceuticals. Ganesh will report to our President and CEO, Apurva Saraf, and will be based out of our office at South Plainfield, New Jersey. In this critical role, Ganesh's expertise in leveraging IT to streamline processes to increase both efficacy and efficiencies in our core areas of manufacturing, supply chain, quality, finance etc. will help us strongly deliver on our growth strategy of inorganic and organic growth through relentless execution.

Ganesh Pillarisetti has joined the executive team as Vice President, IT at Cosette Pharmaceuticals. Ganesh will report to our President and CEO, Apurva Saraf, and will be based out of our office at South Plainfield, New Jersey. In this critical role, Ganesh's expertise in leveraging IT to streamline processes to increase both efficacy and efficiencies in our core areas of manufacturing, supply chain, quality, finance etc. will help us strongly deliver on our growth strategy of inorganic and organic growth through relentless execution.

Bridgewater, NJ. July 6, 2022. Cosette Pharmaceuticals, Inc., a New Jersey-based specialty pharmaceutical company, today announced the appointment of Rick Casten as Chief Financial Officer (CFO), bolstering its executive leadership team.

BRIDGEWATER, NJ – JUNE 7, 2022: Cosette Pharmaceuticals, Inc., a New Jersey-based specialty pharmaceutical company, announced today that the U.S. Patent and Trademark Office (USPTO) issued U.S. Patent No. 11,291,628 for Welchol® Chewable Bar, the Company’s novel drug delivery system of Colesevelam that is easy to handle and ingest, which provides patent protection until 2037.

Bridgewater, NJ and Vadodara, India May 24, 2022/PRNewswire/Cosette Pharmaceuticals, Inc ("Cosette"), in collaboration with Aleor Dermaceuticals, a wholly owned subsidiary of Alembic Pharmaceuticals (“Alembic”; BSE: 533573), announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Application (ANDA) for an NBE version of Abreva® (Docosanol cream 10%) in a 2 gm tube and pump formats. Shipments of the product will begin imminently.

Cosette Pharmaceuticals, Inc., a New Jersey-based pharmaceutical company, today announced the launch of Prochlorperazine Edisylate injection, 10 mg/2ml (5mg/ml).

Cosette Pharmaceuticals, Inc., a New Jersey-based specialty pharmaceutical company, announced today that it has closed a transaction to acquire the US sales and distribution rights to eight branded commercial products from leading Japanese pharmaceutical company, Daiichi Sankyo Company, Ltd (4568:JP) and affiliates.

We are pleased to announce Mindy Hanna has joined Cosette Pharmaceuticals as Senior Director, Human Resources.  Mindy will report to Apurva Saraf and will be based in the South Plainfield office.

Solaris Pharma Corporation (“Solaris” or the “Company”) announced today that the Company has received an abbreviated new drug application (“ANDA”) approval from the U.S. Food and Drug Administration (“FDA” or “Agency”) for the first generic version of Clindagel® (clindamycin phosphate EQ 1%). This product will be manufactured in the United States by Cosette, Solaris’ manufacturing partner. The product will be launched immediately.